Navin Fluorine International Ltd

Q3 FY25Chemicals & Petrochemicals

Navin Fluorine International Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹8,206

Market cap₹42.3K Cr

P/E53.1

Updated23 Aug 2026

Read4 min read

The short version

Strong growth visibility for FY '26: Particularly in CDMO and Specialty Chemicals driven by ongoing projects and order pipeline. Company aims to achieve a sustainable EBITDA margin near 25% by FY '25 end, up from 15% previously.

From Navin Fluorine International Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Strong growth visibility for FY '26: Particularly in CDMO and Specialty Chemicals driven by ongoing projects and order pipeline.
Project Nectar: Focus on dedicated capacity ramp-up in the first year; open capacity qualification and additional molecule development expected to drive growth in the second year.
Agro Specialty Plant at Dahej: Commercial dispatches started; peak revenue expected around FY '27 with gradual ramp-up.
R32 Capacity Expansion: Additional 4,500 MT capacity commissioning by Feb 2025; discussions for further expansion ongoing, with increased demand expected domestically and globally.

2 more points management made on revenue & sales performance

Profitability & Margins

Company aims to achieve a sustainable EBITDA margin near 25% by FY '25 end, up from 15% previously.
Operating EBITDA grew 95% YoY in Q3 FY '25, with margins improving from 15.13% to 24.3%.
Revenue growth driven across all segments: HPP, Specialty Chemicals, and CDMO.
Specialty Chemicals expected to ramp up with new capacity; peak revenue for major projects anticipated by FY '26-FY '27.
CDMO segment expected to exceed $100 million scale with new orders and cGMP4 project commissioning by Q3 FY '26.
New agro specialty plant at Dahej commercialized, contributing to revenue growth.
Employee costs expected to stabilize or decrease slightly, improving cost efficiency.

2 more points management made on profitability & margins

See what Navin Fluorine International Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

INR540 crores capex: Specialty Chemicals project with expected peak annual revenue around INR515 crores, achieving peak in 2 years from commissioning (FY '27).
INR235 crores capex: R32 expansion project underway, discussions ongoing with global majors; potential announcements expected in the first half of FY '26.
INR125 crores capex: Part of ongoing CDMO/cGMP projects.
INR160 crores Phase 1 capex: cGMP4 plant expected to come online in November, with planned accelerated Phase 2 expansion using common infrastructure.
INR30 crores capex: Surat project with asset turn of ~1.2, starting FY '26 with peak in FY '27.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential

1Shiv Texchem Ltd₹265 Cr

Rev 1Mar 2

2Solar Industries₹1.8L Cr

Rev 2Mar 1

3₹1.7K Cr

Rev 2Mar 1

4₹4.8K Cr

Rev 2Mar 3

5₹3.7K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

There is no explicit mention of any current or planned fundraising through debt or equity in the provided transcript.
The company reported a net debt to equity ratio of 0.41 as of December 31, 2024, indicating manageable leverage.
Capex projects are being funded and progressing as planned, with discussions ongoing for potential expansions (e.g., R32 capacity), but no specific details on external fundraising were disclosed.
Management indicated that upcoming capex and growth projects will be driven through internal cash flows and existing resources.

2 more points management made on fundraising & capital structure

See what Navin Fluorine International Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The CDMO business has a strong order book and visibility for FY '26 and beyond, with orders already secured for calendar year (CY) 2025.
A major European customer has placed an order with supply scheduled for FY '26.
U.S.-based major customers have given scale-up orders planned for Q4 FY '25.
The Fermion contract is expected to contribute about 30% towards the $100 million CDMO target by FY '27.
For MPP and dedicated multipurpose plants, the order book visibility is close to peak annual revenue levels for FY '26, with ongoing efforts to secure higher volumes.

2 more points management made on order book & pipeline

Navin Fluorine International Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹938 Cr, net profit ₹213 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Navin Fluo.Intl.'s management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Navin Fluorine International Ltd Q3 FY25 results?

What is Navin Fluorine International Ltd share price analysis?

Navin Fluorine International Ltd currently shows a neutral. The stock trades at a P/E of 53.1 with a market cap of ₹42,251 Cr. Investors should review the full earnings analysis for detailed insights.

Is Navin Fluorine International Ltd planning capital expenditure?

INR540 crores capex: Specialty Chemicals project with expected peak annual revenue around INR515 crores, achieving peak in 2 years from commissioning (FY '27).

Keep Navin Fluorine International Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.